{{Rsnum
|rsid=1654260
|Chromosome=19
|position=20218302
|Orientation=plus
|GMAF=0.376
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.3 | 29.2 | 58.5
| HCB | 22.2 | 51.1 | 26.7
| JPT | 30.2 | 41.9 | 27.9
| YRI | 32.3 | 46.8 | 21.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 22.2 | 51.1 | 26.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=8E-6
  |OR=1.75
  |ORtxt=[1.365-2.24]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}